Newton-based Thermalin plans human tests of concentrated insulin next year
July 28, 2014 at 12:51 PM EDT
As the number of diabetics worldwide skyrockets, a small Newton company developing new types of insulin has closed on $1...
Newton-based Thermalin plans human tests of concentrated insulin next yearJuly 28, 2014 at 12:51 PM EDT
As the number of diabetics worldwide skyrockets, a small Newton company developing new types of insulin has closed on $1...
Related Stocks:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|